Strategic objectives

• Synthesise a platform of dendritic systems with the capacity to act as non-viral vectors for the transport of drugs and nucleic acids.
• Synthesise a platform of dendritic systems with therapeutic activity per se, against cancer, microbial diseases or as antiviral agents.
• Establish collaborations with groups belonging to the Institute that may have research interests common to our group.
• To try to participate in the application for European projects in which the Institute could be eligible.

Research lines

• Synthesis of carbosilane-type dendritic systems for their application as non-viral vectors for drugs or nucleic acids or as therapeutic agents.
• Dendronisation of molecules of pharmacological interest (drugs, peptides, antibodies, etc.) 
• Preparation of metallodendritic systems of carbosilane nature oriented towards bioinorganic applications. 
• Dendronisation of nanostructured materials for their application in biomedicine.
• Synthesis of dendritic nanogels for drug encapsulation
• Application of dendritic systems against microbial resistance. 
• Application of dendritic systems against viruses, particularly HIV. 
• Applications of dendritic systems against cancer. 
• Applications of dendritic systems against neurodegenerative diseases.